Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence
- PMID: 26828052
- DOI: 10.1183/13993003.01891-2015
Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence
Comment in
-
Paediatric study of bedaquiline remains an "open issue".Eur Respir J. 2016 Sep;48(3):956-7. doi: 10.1183/13993003.00628-2016. Eur Respir J. 2016. PMID: 27581412 No abstract available.
-
New anti-tuberculosis drugs for special populations: a difficult-to-address issue.Eur Respir J. 2016 Sep;48(3):957-8. doi: 10.1183/13993003.01289-2016. Eur Respir J. 2016. PMID: 27581413 No abstract available.
Comment on
-
Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis.Eur Respir J. 2016 Feb;47(2):564-74. doi: 10.1183/13993003.00724-2015. Epub 2015 Dec 2. Eur Respir J. 2016. PMID: 26647431 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources